In conjunction with ZERO — The End of Prostate Cancer, CURE® recently hosted the “Educated Patient® Webinar: Advancing Equity in Prostate Cancer Care.”
In conjunction with ZERO — The End of Prostate Cancer, CURE® recently hosted the “Educated Patient® Webinar: Advancing Equity in Prostate Cancer Care,” hosted by Darlene Dobkowski, Associate Editorial Director for CURE®.
A panel of experts shared their insights and answered viewer questions during the webinar. These individuals included: Dr. Scott T. Tagawa, professor of medicine and urology and co-leader of the experimental therapeutics program at Weill Cornell Medicine in New York; Dr. Francisco Gelpi, urologic oncologist at Houston Metro Oncology in Texas; and Kris Bennett, director of health equity, community organizing and engagement for ZERO — The End of Prostate Cancer, a national nonprofit organization that aims to advance research, encourage action and provide education and support to men and their families.
Here are the topics that were discussed during the webinar — as well as some questions that were answered.
Disparities in Screening and Testing in Prostate Cancer
Minimally Invasive Treatment Options for Radiation, Side Effect Management
Symptoms of an Enlarged Prostate, Treatment and Education Around Benign Prostatic Hyperplasia (BPH)
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.